L'acquisition renforce les capacités de production de peptides aux États-Unis et élargit l'expertise mondiale en matière d'API peptidiques complexes CordenPharma a conclu un accord pour l'acquisition d'AmbioPharm, une CDMO de peptides basée aux États-Unis et disposant d'installations à...
Hence then, the article about cordenpharma acquiert ambiopharm pour accroitre sa capacite mondiale de production d api peptidiques was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CordenPharma acquiert AmbioPharm pour accroître sa capacité mondiale de production d'API peptidiques )
Also on site :
- Doctor Says Kyle Busch’s Death Was ‘Totally Preventable,’ Lacked 'Protocol'
- Canadian PM warns oil-rich province against Brexit-style split
- Martin Short Made The Call That Led To Late Daughter Katherine Being Found